Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2019 Financial Results 2018-11-20 19:00
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million 2018-11-20 12:53
Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer 2018-11-19 22:45
Patient Blood Management presented to the U.S.-China Health Summit by IFPBM 2018-11-19 20:53
Cedrus Investments Hosted Life Sciences Forum and Dinner 2018-11-16 09:00
F1 Oncology's International Affiliate, EXUMA Biotechnology, Announces Acquisition Of Strategic CAR-T Assets 2018-11-13 22:00
Esco Medical secures CFDA approval on the MIRI(R) TL and MIRI(R) Embryo Incubators 2018-11-13 10:00
NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab) 2018-11-13 08:00
Angion Biomedica and Sinovant Sciences Enter into Collaboration and License Agreement to Develop BB3 in Greater China 2018-11-13 05:30
Johnson & Johnson Asia Pacific Regional Counsel Eric Wu Returns to Ropes & Gray in Shanghai 2018-11-13 03:16
Ascletis Appoints Dr. Lindi Tan as Chief Financial Officer 2018-11-12 07:30
Head of Global Patient Access Joins Inceptua 2018-11-09 18:40
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC at Asia Conference on Lung Cancer 2018 2018-11-09 15:18
WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting 2018-11-07 17:51
Marken Assists In Fight Against Polio 2018-11-06 19:00
Merck Launches BioContinuum (TM) Platform for Next-Generation Process Improvements 2018-11-05 23:00
Cedrus Investments' Head of Life Sciences Ms. Kimberly Nearing invited to speak at LIFE SCIENCES SUMMIT IN NEW YORK CITY 2018-11-05 09:00
Beijing United Family Hospital successfully applies robotic surgery in new indication 2018-11-01 14:57
Tychan Successfully Completes Human Safety Studies for the First-in-Class Potent Monoclonal Antibody against Zika Virus 2018-10-29 21:29
WuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed 2018-10-29 20:10
1 191 192 193 194 195 229